Clinical Trials Insight: 700038864
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2010
At a glance
- Drugs Phenelzine; Rasagiline; Selegiline
- Indications Parkinson's disease
- Focus Pharmacodynamics; Registrational
- Sponsors Teva Pharmaceutical Industries
- 03 Jun 2010 Results of this trial have been published in the Journal of Clinical Pharmacology, according to a Teva Neuroscience media release.
- 05 May 2010 Results published in the Journal of Clinical Pharmacology.
- 09 Jun 2009 Results reported at 13th International Congress of Parkinson's Disease and Movement Disorders (PDMD), according to a Teva Neuroscience media release.